Replies to post #380930 on Innovation Pharmaceuticals Inc (IPIX)

[steelyeye]

Yep, and it could come quickly. I can hardly wait for # 10 on this list to materialize as very positive PH II results:

So far many signs are converging:

1. FDA fast track designation- January

2. Validation by 2 independent machine learning studies- March
https://www.ipharminc.com/press-release/2021/3/10/innovation-pharmas-covid-19-drug-candidate-brilacidin-ranked-in-top-three-percent-of-compounds-predicted-to-be-most-effective-against-sars-cov-2

3. Peer-Reviewed scientific article published in journal Viruses- March-- https://www.mdpi.com/1999-4915/13/2/271

4. 2 separate Data Monitoring Committee safety reviews are completed on PH II patients- April and after.

5. Subsequent FDA approved Compassionate use begins in hospitalized patients using Brilacidin.

6. PH II results anticipated week of Nov. 8th

7. Management 8ks new milestone-based incentive package for CEO and Board on Oct. 14

8. Dr. Degrado, IPIX scientific advisor and developer of Brilacidin publishes new paper and gives prestigious lecture on de novo design of membrane-interactive peptides. Oct. 21st

9. IPIX share price continues to rise last few sessions

10.